Invesaro

Stocks OKTA Financial statements

Financial statements

Okta, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Okta, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2018FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue1612603995868351,3001,8582,2632,6102,919
Cost of revenue55.980.8113159218396546581618661
Gross profit1051762864276179041,3121,6821,9922,258
Research and development38.770.8102159223469620656642639
Selling and marketing1111652283404277711,0661,0369651,018
General and administrative30.151.875.1113171432409450448448
Operating expenses1802884056138211,6722,1242,1982,0662,109
Operating income-74.7-112-120-186-204-768-812-516-74149
Interest expense0015.127739111854
Other non-operating income0.041.689.1817.11392281106110
Pre-tax income-74.6-110-126-210-266-850-801-33746255
Income tax0.43-0.32-0.02-1.420-214181820
Net income-75.1-110-125-209-266-848-815-35528235
EBITDA-72.3-108-114-177-195-756-800-504-61162
EPS, basic-3.94-1.32-1.17-1.78-2.09-5.73-5.16-2.170.161.33
EPS, diluted-3.94-1.32-1.17-1.78-2.09-5.73-5.16-2.170.061.31
Shares, basic (weighted)1983108117127148158164170176
Shares, diluted (weighted)1983108117127148158164175179

Balance sheet

FY2018FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents23.3128298520435260264334409858
Short-term investments14.41022658832,1222,2422,3161,8682,1141,695
Receivables34.552.291.9130195398481559621687
Other current assets7.0317.828.23381.66676106132233
Total current assets92.83177081,6002,8793,0413,2292,9803,4163,644
Property, plant and equipment1112.552.953.562.86559484338
Lease right-of-use assets121125150148122837465
Goodwill2.636.2818.148485,4015,4005,4065,4485,487
Intangible assets9.1611.813.932.52731724118213891
Other non-current assets4.9810.415.118.524.34346485153
Total assets1313999841,9553,2999,2069,3078,9899,4379,710
Accounts payable9.399.572.433.848.562012121312
Accrued liabilities4.33.3921.222.524.7485248207213
Deferred revenue1081602463655039731,2421,4881,6911,875
Total current liabilities1341885735471,5461,2431,4651,7822,5232,554
Lease liabilities1471551801711421129472
Other non-current liabilities6.087.023.025.3611.43123303955
Total liabilities1462007321,5502,6053,2843,8413,1013,0322,711
Paid-in capital44.55667451,1061,6567,7507,9748,7249,2199,553
Retained earnings-288-367-492-701-967-1,816-2,475-2,830-2,802-2,567
Other comprehensive income-0.170.39-0.320.895.39-12-33-6-1213
Shareholders' equity-2121992524056935,9225,4665,8886,4056,999
Total equity-2121992524056935,9225,4665,8886,4056,999
Total liabilities and equity1313999841,9553,2999,2069,3078,9899,4379,710

Cash flow statement

FY2018FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income-75.1-110-125-209-266-848-815-35528235
Depreciation and amortization2.445.78.891212121313
Stock-based compensation17.149.976.3127195566677684565544
Deferred income tax-0.02-0.5-0.75-2.36-1-677212
Change in receivables-12-18.3-39.7-37.5-66-175-87-79-63-70
Change in payables1.53-2.46-1.441.6947-601-2
Cash from operations-42.1-25.215.255.612810486512750884
Capital expenditures-6.25-6.55-19.8-15.4-13-13-12-8-8-9
Acquisitions00-15.6-44.30-215-4-22-56-56
Purchases of investments0-129-631-999-2,029-1,847-1,411-1,709-1,812-1,505
Sales and maturities of investments12.539.82993565351,4821,3082,1341,5711,848
Cash from investing6.97-99.7-197-688-1,305-367-130441-314271
Stock issued2.4433.636.945.4455317152712
Share buybacks00-73
Cash from financing0.462373588531,0928948-883-359-720
Exchange rate effect-0.120.49-0.63-0.212-2-61-414
Net change in cash-34.8113175221-83-176-27173449
Free cash flow-48.4-31.8-4.6440.21159174504742875
Interest paid0.020.40.8646653
Income taxes paid00.750.511.12138131710

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $195.19 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin78.1%Gross profit / revenue.
Operating margin7.5%Operating income / revenue.
Pre-tax margin10.5%Pre-tax income / revenue.
Net margin9.6%Net income / revenue.
FCF margin31.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin32.1%Cash from operations / revenue.
Effective tax rate8.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)4.2%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)3.2%Net income / average total assets.
Return on invested capital (ROIC)3.4%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue21.2%Research and development expense / revenue.
Stock-based pay / revenue16.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.3%Capital expenditures / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y11.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y16.3%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y28.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y13.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y19.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y29.6%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y739.3%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y2,083.0%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y17.9%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y117.4%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y47.2%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y17.9%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y127.8%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y50.1%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y9.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y8.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y58.8%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y2.9%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y1.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y24.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y2.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y4.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y7.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.53xCurrent assets / current liabilities.
Quick ratio1.37x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.14x(Cash + short-term investments) / current liabilities.
Liabilities / assets23.7%Total liabilities / total assets.
Interest coverage77.3xOperating income / interest expense.
Working capital$1.06BCurrent assets - current liabilities.
Goodwill and intangibles / assets60.9%(Goodwill + intangible assets) / total assets.
Tangible book value$1.41BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.34xRevenue / average total assets.
Fixed asset turnover93.1xRevenue / average property, plant and equipment.
Receivables turnover6.55xRevenue / average receivables.
Days sales outstanding56 days365 x average receivables / revenue.
Days payables5 days365 x average accounts payable / cost of revenue.
FCF conversion330.7%Free cash flow / net income, when net income is positive.
Capex / operating cash flow0.8%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.66Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$17.19Revenue / diluted weighted shares.
FCF per share$5.48Free cash flow / diluted weighted shares.
Operating cash flow per share$5.52Cash from operations / diluted weighted shares.
Book value per share$39.00Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$7.86Tangible book value / shares outstanding.
Cash per share$12.86(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$33.93BShare price x shares outstanding.
Enterprise value$31.63BMarket cap + total debt - cash - short-term investments.
P/E115xMarket cap / net income. Only when net income is positive.
P/S11.0xMarket cap / revenue.
P/B4.87xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book24.1xMarket cap / tangible book value, when positive.
P/FCF34.7xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF34.4xMarket cap / cash from operations, when positive.
EV/Sales10.3xEnterprise value / revenue.
EV/EBIT136xEnterprise value / operating income, when both are positive.
EV/FCF32.3xEnterprise value / free cash flow, when both are positive.
FCF yield2.9%Free cash flow / market cap.
Earnings yield0.9%Net income / market cap (the inverse of P/E).
What was Okta, Inc.'s revenue in fiscal 2026?

Okta, Inc. reported revenue of $2.92B for fiscal 2026, 11.8% higher than the year before.

Was Okta, Inc. profitable in fiscal 2026?

Yes. Net income was $235.0M, a net margin of 8.1%.

How much free cash flow did Okta, Inc. generate in fiscal 2026?

Cash from operations of $884.0M minus capital expenditures of $9.0M left free cash flow of $875.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Okta, Inc.